Watchdog Group: Remove ALS Drug Relyvrio From Market Now Watchdog Group: Remove ALS Drug Relyvrio From Market Now

The watchdog group Public Citizen is calling for the prompt removal of the ALS drug Relyvrio after it failed to meet primary and secondary endpoints in top-line results from a phase 3 trial.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Source Type: news